Southern Illinois University Carbondale

OpenSIUC
Posters

REACH

3-26-2010

Modification and Stabilization of MHC Class I
Molecules for Use in DNA Vaccine
Gregory Cresswell
Southern Illinois University Carbondale

John Martinko
Southern Illinois University Carbondale

Follow this and additional works at: http://opensiuc.lib.siu.edu/reach_posters
Recommended Citation
Cresswell, Gregory and Martinko, John, "Modification and Stabilization of MHC Class I Molecules for Use in DNA Vaccine" (2010).
Posters. Paper 1.
http://opensiuc.lib.siu.edu/reach_posters/1

This Article is brought to you for free and open access by the REACH at OpenSIUC. It has been accepted for inclusion in Posters by an authorized
administrator of OpenSIUC. For more information, please contact opensiuc@lib.siu.edu.

Modification and Stabilization of MHC Class I Molecules
for use in DNA Vaccines
Gregory Cresswell
Department of Microbiology
Dr. John Martinko

Abstract

Figure 2. The disulfide trap site. Tyr84 is replaced with cysteine in the disulfide trap.
Image taken from Journal of Immunology 2007.

Methods
Site-Directed Mutagenesis
DNA primers were designed to mutate the original SIINFEKL
peptide to the new peptides SIINHEKL and SIINYEKL. Both disulfide
trap and non-disulfide trap models were created.
Transformation
The mutated strands were then transformed into E. coli for
amplification of the DNA. The plasmid carrying the DNA carries
genes for ampicillin resistance. The E. coli were grown on LB agar
with 50 µg/mL of ampicillin. Once grown on plates, resistant colonies
from the plates were transferred to LB broth with 50 µg/mL of
ampicillin. Ten liquid cultures were made and then used for DNA
extraction.
Plasmid Preparation
A plasmid preparation was used extract the DNA from the E. coli
liquid cultures.
DNA Gel Electrophoresis
The purified DNA from the plasmid preparation was then cut with the
BamH1 restriction enzyme. This cuts the DNA into fragments for
visualization on the gel.
Transfection
293T cells were used to generate viral particles carrying the mutated
DNA strands. Those viral particles were then used on LM18 mice
cells to create a new cell line expressing SIINHEKL or SIINYEKL.
The plasmid tranfsected into the cell lines carried genes for
hgyromycin resistance. This was used as the selective agent to
eliminate non-transfected cells.
The cell lines were then analyzed for expression of the SCT MHC
Class I through a B3Z Assay.
B3Z Assay
B3Z T cells carry the lac Z operon and have T cell receptors specific
for the SIINFEKL-Kb epitope. These cells were used to measure
expression of the SCT in transfected cell lines. B3Z cells that bound
the SCTs were activated and cleaved MUG ( a lac Z substrate) to
generate a color change. This was quantitatively measured to
determine expression.

Figure 1. Single Chain Trimer MHC Class I Molecule
The alpha chain (blue) is linked (red) to the β2-microglobulin (purple)
and the peptide is connected to the linker (red) on the β2-microglobulin.
The disulfide trap is in green.
Image taken from Journal of Immunology 2007.

Cell Lines

Major Histocompatibility Complex class I molecules present
antigens to the immune system. A mouse MHC class I gene,
H-2Kb, was modified by linking individual subunits together with a
peptide antigen to form a single chain trimer (SCT). A disulfide
bond, termed the disulfide trap, was added to stabilize the
preloaded antigen (Figure 1 and Figure 2). The original antigen
peptide, SIINFEKL, was modified to test the disulfide trap for
stabilization of MHC class I SCT with a modified antigen. The
SIINFEKL antigen was modified to SIINHEKL and SIINYEKL. DNA
primers were designed to mutate the phenylalanine (F) amino acid
to histidine (H) or tyrosine (Y). This was done through site directed
mutagenesis, transformation, and transfection into tissue culture
cells. Modifications of the peptide were tested using B3Z T cells
that specifically recognize the SIINFEKL-Kb epitope. Cells
expressing the disulfide trap proved to be very stable and
presented a recognizable antigen to the T cells even when the
original peptide had been modified. SCTs without the disulfide trap
were weakly presented to the T cells. SCTs containing the mutant
SIINYEKL or SIINHEKL peptides lacking the disulfide trap were not
as stable and did not fold or present peptides well. In particular,
the SIINHEKL modification showed that the disulfide trapped SCT
was recognized by the T cells. However, the non-trapped
SIINHEKL showed a significant reduction in epitope expression.
The SIINYEKL mutants showed similar results. This indicates that
peptides of our design can be presented efficiently to the immune
system with disulfide trap stabilization. Further application of this
research may allow construction of DNA vaccines expressing
custom antigens.

Results and Discussion

Epitope Recognition (Relative Optical Density Units)
Figure 3. T cell epitope assay of SCT MHC proteins. B3Z T cells, specific for the SIINFEKL–Kb
MHC I epitope were used to assay the expression levels of both natural and mutated versions of the
epitope in transfected cell lines. YC: SIINYEKL with the disulfide trap. YA: SIINYEKL without the
disulfide trap. HC: SIINHEKL with disulfide trap. HA: SIINHEKL without disulfide trap. FC:
SIINFEKL with disulfide trap. FA: SIINFEKL without disulfide trap. S: Cell line that has been kept
under selective pressure. B3Z are the B3Z cells alone. Lm18 is a cell line that is not expressing
the Kb epitope. Lm18 Kb is a cell line expressing only the Kb epitope and not the SCT.

We showed that an SCT model of the MHC class I molecule
can be generated and expressed in cell lines. All class I MHC SCT
molecules generated in this study are recognized by the B3Z T cell,
indicating that the mutations introduced to generate the disulfide trap
to alter the major anchor residues in SIINFEKL did not destroy the T
cell epitope: with or without the disulfide trap, the native SIINFEKL
SCT and the SCTs containing the SIINHEKL and SIINYEKL peptides
maintained T cell epitope expression. The B3Z T cells specific for the
SIINFEKL peptides recognized the altered peptides and disulfide
trapped constructs in every case.
With the native SIINFEKL peptide, the disulfide trap partially
reduced expression of the T cell epitope (Figure 3). In the both
cases where the native peptide was altered, however, the disulfide
trap provided increased T cell epitope stability; both SIINYEKL and
SIINHEKL disulfide trapped molecules were recognized better than
the non-trapped molecules ( Figure 3). This was especially evident
for SIINHEKL where the non-disulfide trapped molecule showed
significantly reduced expression of the T cell epitope, relative to all
other SCT constructs. The disulfide-trapped SIINHEKL molecule, on
the other hand, showed enhanced expression of the T cell epitope,
indicating significant stabilization of the epitope due to the disulfide
trap.
The native SIINFEKL-Kb SCT is shown with and without
disulfide trap along with cell lines that were kept under antibiotic
selective pressure to enhance expression of the SCT DNA. There
were no observable difference in SCT expression between cells kept
under selection and those that were not kept under selection; the
comparison between selected and unselected cell lines did not
significantly alter surface recognition of the T cell epitope, indicating
that selective pressure is not needed for the cells to maintain and
express the transfected DNA. Thus, the SCT disulfide trapped MHC
is very stable once it has been introduced into the cell. This stability
is further proof of concept for application in DNA vaccines.

